Description: Bioanalysis for support of next generation Antibody siRNA Conjugates (ARCs) have exploded recently. Several case studies will be shown that highlight the PK, Immunogenicity, and PD/BM bioanalytical approaches for ARCs and siRNA using QqQ, HRMS, Molecular, and hybrid ELISA . A novel 1.5 plex ARC assay will be presented to detect total antibody and antisense & total antisense and a novel ADA bridging assay.
Learning Objectives:
Understanding the options for PK, Immunogenicity, and PD/BM Bioanalysis of ARCs/Oligos
Understand the bioanalytical challenges associated with antibody siRNA conjugates (ARCs)
Understand the different strategies for developing "Oligonucleotide assays" - based on Modality – ARC/siRNA/ASO, QqQ vs HRMS, Immunogenicity (ADA)